Trial · NCT03428360
Adverse events35
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 35
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Seizure | Nervous system disorders | Safety Analysis Set | 26 | 130 | 98 |
| other | Somnolence | Nervous system disorders | Safety Analysis Set | 6 | 130 | 6 |
| other | Lethargy | Nervous system disorders | Safety Analysis Set | 4 | 130 | 5 |
| other | Dizziness | Nervous system disorders | Safety Analysis Set | 4 | 130 | 4 |
| other | Headache | Nervous system disorders | Safety Analysis Set | 4 | 130 | 4 |
| other | Upper respiratory tract infection | Infections and infestations | Safety Analysis Set | 8 | 130 | 8 |
| other | Sinusitis | Infections and infestations | Safety Analysis Set | 6 | 130 | 6 |
| other | Ear infection | Infections and infestations | Safety Analysis Set | 4 | 130 | 4 |
| other | Vomiting | Gastrointestinal disorders | Safety Analysis Set | 7 | 130 | 8 |
| other | Nausea | Gastrointestinal disorders | Safety Analysis Set | 5 | 130 | 5 |
| other | Diarrhoea | Gastrointestinal disorders | Safety Analysis Set | 4 | 130 | 6 |
| other | Fall | Injury, poisoning and procedural complications | Safety Analysis Set | 5 | 130 | 7 |
| other | Skin abrasion | Injury, poisoning and procedural complications | Safety Analysis Set | 4 | 130 | 5 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Safety Analysis Set | 5 | 130 | 6 |
| other | Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | Safety Analysis Set | 4 | 130 | 4 |
| other | Pyrexia | General disorders | Safety Analysis Set | 7 | 130 | 12 |
| other | Weight decreased | Investigations | Safety Analysis Set | 4 | 130 | 6 |
| other | Weight increased | Investigations | Safety Analysis Set | 4 | 130 | 6 |
| serious | Seizure | Nervous system disorders | Safety Analysis Set | 1 | 130 | 1 |
| serious | Epilepsy | Nervous system disorders | Safety Analysis Set | 1 | 130 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03428360/events